ES2169113T3 - Nuevos compuestos amido-triciclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. - Google Patents
Nuevos compuestos amido-triciclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.Info
- Publication number
- ES2169113T3 ES2169113T3 ES95402331T ES95402331T ES2169113T3 ES 2169113 T3 ES2169113 T3 ES 2169113T3 ES 95402331 T ES95402331 T ES 95402331T ES 95402331 T ES95402331 T ES 95402331T ES 2169113 T3 ES2169113 T3 ES 2169113T3
- Authority
- ES
- Spain
- Prior art keywords
- alkyl
- cycloalkyl
- substd
- alkoxy
- alkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/92—Naphthofurans; Hydrogenated naphthofurans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/12—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups
- C07C233/13—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by halogen atoms or by nitro or nitroso groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/20—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/60—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Transplantation (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
COMPUESTOS DE FORMULA(I) EN LA QUE R 1 REPRESENTA UNA CADENA (C{SUB,1-4} ALQUILENO NO SUSTITUIDA O SUSTITUIDA POR UN RADICAL ELEGIDO ENTRE ALQUILO, HIDROXI, ALCOXICARBONILO Y CARBOXILO; . R{SUP,2} REPRESENTA UN ATOMO DE HIDROGENO O UN ALQUILO, R{SUP,3} REPRESENTA BIEN UN GRUPO DE FORMULA R{SUP,31} EN EL QUE N REPRESENTA CERO O UN NUMERO ENTERO DE 1 A 3 Y R{SUP,5} REPRESENTA UN ATOMO DE HIDROGENO, UN ALQUILO NO SUSTITUIDO O SUSTITUIDO, UN ALCENILO NO SUSTITUIDO O SUSTITUIDO, UN ALCINILO NO SUSTITUIDO O SUSTITUIDO, UN CICLOALQUILO NO SUSTITUIDO O SUSTITUIDO, UN DICICLOALQUILALQUILO NO SUSTITUIDO O SUSTITUIDO; Y X'' REPRESENTA UN ATOMO E OXIGENO O DE AZUFRE, BIEN UN GRUPO DE FORMULA R{SUP,32} EN EL QUE X REPRESENTA UN ATOMO DE OXIGENO O DE AZUFRE, M REPRESENTA CERO O UN NUMERO ENTERO DE 1 A 3 Y R{SUB,6} REPRESENTA UN RADICAL ELEGIDO ENTRE LOS MISMOS VALORES QUE R{SUP,5}, A REPRESENTA UNA CADENA DE FORMULA -O-A{SUP,1} EN LA QUE A{SUP,1} ES UNA CADENA ELEGIDA ENTRE ALQUILENO C{SUB,2-5}, ALCENILENO C{SUB,2-5} Y ALCINILENO C{SUB,2-5}; SIENDO A{SP,1} NO SUSTITUIDO O SUSTITUIDO POR UNO O VARIOS GRUPOS ELEGIDOS ENTRE ALQUILO, ALCOXI, HIDROXI Y OXO. FORMANDO Y CON EL NUCLEO AL QUE ESTA ASOCIADO UN GRUPO Y{SUP1} ELEGIDO ENTRE NAFTALENO ,NAFTALENO PARCIALMENTE HIDROGENADO, BENZOFURANO, BENZOFURANO PARCIALMENTE HIDROGENADO, BENZOTIOFENO, BENZOTIOFENO PARCIALMENTE HIDROGENADO, E INDOL; Y SU PREPARACION PARA EL TRATAMIENTO DE LOS TRASTORNOS DEL SISTEMA METALONINERGICO
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9412581A FR2725985B1 (fr) | 1994-10-21 | 1994-10-21 | Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2169113T3 true ES2169113T3 (es) | 2002-07-01 |
Family
ID=9468074
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95402331T Expired - Lifetime ES2169113T3 (es) | 1994-10-21 | 1995-10-19 | Nuevos compuestos amido-triciclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. |
Country Status (17)
Country | Link |
---|---|
US (1) | US5843986A (es) |
EP (1) | EP0708099B1 (es) |
JP (1) | JP2999143B2 (es) |
CN (2) | CN1053662C (es) |
AT (1) | ATE209641T1 (es) |
AU (1) | AU688586B2 (es) |
CA (1) | CA2160961C (es) |
DE (1) | DE69524186T2 (es) |
DK (1) | DK0708099T3 (es) |
ES (1) | ES2169113T3 (es) |
FI (1) | FI118565B (es) |
FR (1) | FR2725985B1 (es) |
HK (1) | HK1029116A1 (es) |
NO (1) | NO314262B1 (es) |
NZ (1) | NZ280298A (es) |
PT (1) | PT708099E (es) |
ZA (1) | ZA958894B (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6071946A (en) * | 1994-10-21 | 2000-06-06 | Adir Et Compagnie | Tricyclic urea compounds |
US5998461A (en) * | 1994-10-21 | 1999-12-07 | Adir Et Compagnie | Tricyclic amide compounds |
FR2739379B1 (fr) * | 1995-09-29 | 1997-10-24 | Adir | Nouveaux composes amines de 5,6,7,8-tetrahydronaphto(2,3-b) furane et d'indano(5,6-b)furane, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
EP1199304A1 (en) * | 1997-03-05 | 2002-04-24 | Takeda Chemical Industries, Ltd. | Bicyclic compounds and pharmaceutical composition containing tricyclic compound for treating or preventing sleep disorders |
CN100443480C (zh) † | 1996-03-08 | 2008-12-17 | 武田药品工业株式会社 | 三环化合物及其制备和用途 |
US6034239A (en) * | 1996-03-08 | 2000-03-07 | Takeda Chemical Industries, Ltd. | Tricyclic compounds, their production and use |
TW476758B (en) * | 1996-12-10 | 2002-02-21 | Bristol Myers Squibb Co | Benzodioxole, benzofuran, dihydrobenzofuran and benzodioxane melatonergic agents |
FR2763335B1 (fr) * | 1997-05-16 | 2000-11-24 | Adir | Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2773798B1 (fr) | 1998-01-16 | 2001-02-02 | Adir | Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US6214869B1 (en) | 1998-06-05 | 2001-04-10 | Bristol-Myers Squibb | Heterocyclic cis cyclopropane derivatives as melatonergic agents |
DE60007745T2 (de) | 1999-06-30 | 2005-03-10 | Bristol-Myers Squibb Co. | Heterocyclische aminopyrrolidon-derivate als melatonergene wirkstoffe |
EP1213290B1 (en) | 1999-08-20 | 2005-04-20 | Takeda Pharmaceutical Company Limited | Dihydrobenzofuran derivatives, process for the preparation thereof and agents |
FR2805993B1 (fr) * | 2000-03-08 | 2004-01-16 | Adir | Utilisation de ligands melatoninergiques pour l'obtention de compositions pharmaceutiques destinees a la prevention ou au traitement du developpement de la tolerance aux composes nitres |
US7012090B1 (en) | 2000-03-17 | 2006-03-14 | Alcon, Inc. | Pyranoindoles for treating glaucoma |
AR061478A1 (es) | 2006-06-19 | 2008-08-27 | Takeda Pharmaceutical | Compuesto triciclico y composicion farmaceutica |
KR20090086641A (ko) * | 2006-12-08 | 2009-08-13 | 다케다 야쿠힌 고교 가부시키가이샤 | 삼환 화합물 및 이의 의학적 용도 |
GB201002372D0 (en) | 2010-02-12 | 2010-03-31 | Element Six Production Pty Ltd | A superhard multiphase material and method of using same |
CN107325011A (zh) * | 2016-04-30 | 2017-11-07 | 陕西合成药业股份有限公司 | 一种褪黑激素类化合物及其制备方法和用途 |
CA3220039A1 (en) | 2021-06-14 | 2022-12-22 | Jr. David St. Jean | Urea derivatives which can be used to treat cancer |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2613364B1 (fr) * | 1987-04-01 | 1989-06-09 | Adir | Nouvelles amines tricycliques derivees du tetrahydro-5, 6, 7, 8 naphto (2, 3b) dihydro-2, 3 furanne, et du tetrahydro-6, 7, 8, 9 5h-benzocyclohepta (2, 3b) dihydro-2, 3 furanne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
FR2613365B1 (fr) * | 1987-04-01 | 1989-07-28 | Adir | Nouveaux derives de l'amino tetrahydro-5, 6, 7, 8 naphto (2, 3b) furanne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
FR2658818B1 (fr) * | 1990-02-27 | 1993-12-31 | Adir Cie | Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
FR2680507B1 (fr) * | 1991-08-23 | 1993-10-08 | Adir Cie | Nouvelles naphtylethylurees et naphtylethylthiourees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
FR2689124A1 (fr) * | 1992-03-27 | 1993-10-01 | Adir | Nouvelles naphtylalkylamines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
GB9407919D0 (en) * | 1994-04-21 | 1994-06-15 | Glaxo Group Ltd | Chemical compounds |
-
1994
- 1994-10-21 FR FR9412581A patent/FR2725985B1/fr not_active Expired - Fee Related
-
1995
- 1995-10-18 NO NO19954149A patent/NO314262B1/no not_active IP Right Cessation
- 1995-10-19 DE DE69524186T patent/DE69524186T2/de not_active Expired - Fee Related
- 1995-10-19 US US08/545,395 patent/US5843986A/en not_active Expired - Fee Related
- 1995-10-19 CA CA002160961A patent/CA2160961C/fr not_active Expired - Fee Related
- 1995-10-19 AT AT95402331T patent/ATE209641T1/de not_active IP Right Cessation
- 1995-10-19 ES ES95402331T patent/ES2169113T3/es not_active Expired - Lifetime
- 1995-10-19 DK DK95402331T patent/DK0708099T3/da active
- 1995-10-19 EP EP95402331A patent/EP0708099B1/fr not_active Expired - Lifetime
- 1995-10-19 PT PT95402331T patent/PT708099E/pt unknown
- 1995-10-20 JP JP7272750A patent/JP2999143B2/ja not_active Expired - Fee Related
- 1995-10-20 NZ NZ280298A patent/NZ280298A/en not_active IP Right Cessation
- 1995-10-20 ZA ZA958894A patent/ZA958894B/xx unknown
- 1995-10-20 CN CN95115980A patent/CN1053662C/zh not_active Expired - Fee Related
- 1995-10-20 AU AU34377/95A patent/AU688586B2/en not_active Ceased
- 1995-10-20 FI FI955023A patent/FI118565B/fi active IP Right Grant
-
1999
- 1999-12-15 CN CNB991261585A patent/CN1137889C/zh not_active Expired - Fee Related
-
2000
- 2000-12-28 HK HK00108449A patent/HK1029116A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1263095A (zh) | 2000-08-16 |
CA2160961C (fr) | 2001-07-17 |
EP0708099B1 (fr) | 2001-11-28 |
JPH08239377A (ja) | 1996-09-17 |
FI118565B (fi) | 2007-12-31 |
HK1029116A1 (en) | 2001-03-23 |
CN1130184A (zh) | 1996-09-04 |
CN1053662C (zh) | 2000-06-21 |
CN1137889C (zh) | 2004-02-11 |
PT708099E (pt) | 2002-05-31 |
ATE209641T1 (de) | 2001-12-15 |
AU688586B2 (en) | 1998-03-12 |
NO314262B1 (no) | 2003-02-24 |
DE69524186T2 (de) | 2002-07-04 |
DE69524186D1 (de) | 2002-01-10 |
DK0708099T3 (da) | 2002-02-11 |
JP2999143B2 (ja) | 2000-01-17 |
FR2725985A1 (fr) | 1996-04-26 |
CA2160961A1 (fr) | 1996-04-22 |
FR2725985B1 (fr) | 1996-11-15 |
EP0708099A1 (fr) | 1996-04-24 |
AU3437795A (en) | 1996-05-02 |
NO954149D0 (no) | 1995-10-18 |
US5843986A (en) | 1998-12-01 |
NZ280298A (en) | 1996-10-28 |
ZA958894B (en) | 1996-05-14 |
FI955023A0 (fi) | 1995-10-20 |
FI955023A (fi) | 1996-04-22 |
NO954149L (no) | 1996-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2169113T3 (es) | Nuevos compuestos amido-triciclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
MX9102621A (es) | Nuevos compuestos de hidantoina, procedimiento para su preparacion y composiciones herbicidas que los contienen. | |
ATE184628T1 (de) | Flüssigkristallverbindungen und diese enthaltende flüssigkristallzusammensetzung | |
AU660469B2 (en) | Pharmacologically active hydrazine derivatives and processes for the preparation thereof | |
ES2143154T3 (es) | Compuestos alcoxi-arilos con afinidad para los receptores melatoninergicos, sus procedimientos de preparacion, y las composiciones farmaceuticas que los contienen. | |
ES2157404T3 (es) | Nuevos compuestos alquil-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
NO985516D0 (no) | Nye naftalenforbindelser, en fremgangsmÕte ved deres fremstilling og farmas°ytiske sammensetninger inneholdende dem | |
ES2173087T3 (es) | Compuesto de azetidinona y procedimiento para su preparacion. | |
MX9200206A (es) | 1,2,3,4- TETRAHIDROCICLOPENT (b) INDOLES SUSBSTITUIDOS, 1,2,3,3a-4,8a- HEXAHIDROCICLOPENT (b) INDOLES Y COMPUESTOS RELACIONADOS, COMPUESTOS INTERMEDIOS Y UN PROCEDIMIENTO PARA LA PREPARACIONDE LOS MISMOS Y SU USO COMO MEDICAMENTOS. | |
ES2052181T3 (es) | Derivados de 2-oxo-1-oxa-8-azaespiro(4,5)decano, procesos para su preparacion y composiciones farmaceuticas de los mismos. | |
ATE192927T1 (de) | Neue cephem-derivate | |
DE69425970T2 (de) | Benzol-derivate, verwendbar für ischämische erkrankungen | |
ATE151435T1 (de) | Neue 17,20-epoxyd derivate von pregnan, ihre verwendung zur herstellung von cortison-derivaten und zwischenprodukte dafür | |
ES2074343T3 (es) | Nuevas feniletanolamino- y feniletanolaminometil-tetralinas, procedimiento para su preparacion, intermediarios en este procedimiento y composiciones farmaceuticas que los contienen. | |
BG100887A (en) | Process for the preparation of 7-hydroxy taxanes | |
CA2027542A1 (en) | Uv-absorbing cyclic enaminoketones | |
ATE52501T1 (de) | Cyclohexan-1,3-dionderivate, diese enthaltende zusammensetzungen, verfahren zu deren herstellung und deren verwendung als herbizide und pflanzenwachstumsregulatoren. | |
PT90831A (pt) | Processo para a preparacao de eteres da 2-amino-7-hidroxitetralina | |
SE8401064D0 (sv) | Neue isoxazole und verfahren zu ihrer herstellung | |
ECSP972091A (es) | Compuestos anti-bacteriales de carbapenem, composiciones que los contienen y metodos de tratamiento |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 708099 Country of ref document: ES |